UBS Group’s Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third PANA.U Stock Holding History

UBS Group’s Portfolio PANA.U Stock Details PANA.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-964	Closed	-$12K	–	9906
2020 Q4	$12K	Sell	964 -28,900	-97%	-$319K	﹤0.01%	7388
2020 Q3	$358K	Buy	+29,864	New	+$344K	﹤0.01%	4415

UBS Group's PANA.U Position: Q1 2021 in Review

UBS Group sold out of Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third (PANA.U) in Q1 2021, closing a stake of 964 shares — an estimated $12K sold.

UBS Group first reported a position in PANA.U in Q3 2020 and held it in 2 quarters. The position peaked at $358K in Q3 2020. 0 funds tracked by Wall St. Rank hold PANA.U as of Q1 2021.

UBS Group reported no remaining Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third position as of Q1 2021 after selling out during the quarter.
UBS Group sold 964 Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third shares in Q1 2021, an estimated $12K.
UBS Group first reported a position in Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third in Q3 2020 and held it in 2 quarters.
UBS Group's Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third position peaked at $358K in Q3 2020.
0 funds tracked by Wall St. Rank held Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third as of Q1 2021.

Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.